Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice

Endoxifen, an active metabolite of tamoxifen, has been shown to be an effective anti-estrogenic agent in estrogen receptor-positive breast cancer patients. In melanoma, estrogen receptor expression is shown to be associated with disease progression. However, the therapeutic benefit of endoxifen in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Paul, Sheikh, Saifuddin, Ahmad, Ateeq, Ali, Shoukath M., Ahmad, Moghis U., Ahmad, Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751858/
https://www.ncbi.nlm.nih.gov/pubmed/29308069
http://dx.doi.org/10.1186/s11658-017-0068-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751858/
https://www.ncbi.nlm.nih.gov/pubmed/29308069
http://dx.doi.org/10.1186/s11658-017-0068-7

Ejemplares similares